Finnegan, Henderson, Farabow, Garrett & Dunner, L.L.P.
Cyclic peptide compounds
The present invention relates to a new cyclic peptide compound or a salt thereof, which has anti-hepatitis C virus activities based on inhibitory activity against the RNA replication of hepatitis C virus replicon, a process for preparation thereof, a pharmaceutical composition comprising the same, and a method for prophylactic and/or therapeutic treatment of hepatitis C in a human being or an animal.
Astellas Pharma Inc.
A C A A
A61P C07K A61K A61P
inventional inventional additional inventional
Shigeki Junya Hiroaki Yu Hidenori Toshio Ayako Hiroaki Takuya
Kunikawa Ishida Ohtake Harayama Ohki Yamanaka Toda Mizuno Makino